Related Experiment Video
Updated: Aug 9, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
[Thrombus aspiration therapy for acute coronary syndrome]
1Department of Internal Medicine, Sakurabashi Watanabe Hospital.
Insights
Reducing clot burden before percutaneous coronary intervention may improve blood flow in acute myocardial infarction patients. However, current devices show limited evidence of improving clinical outcomes, necessitating further research.
Area of Science:
- Cardiology
- Interventional Cardiology
- Biomedical Engineering
Context:
- Acute myocardial infarction (AMI) management aims to restore blood flow.
- Reducing intracoronary thrombus burden before percutaneous coronary intervention (PCI) is a potential strategy for improving myocardial reperfusion.
- Existing thrombus removal devices include X-sizer, AngioJet, and aspiration systems.
Purpose:
- To evaluate the efficacy of intracoronary thrombus removal devices in patients with AMI.
- To assess the impact of thrombus removal on myocardial reperfusion and clinical outcomes.
- To identify patient and lesion characteristics that may predict benefit from thrombus removal therapy.
Summary:
- Randomized studies using X-sizer and AngioJet suggest possible benefits in myocardial reperfusion but lack definitive proof of improved clinical outcomes.
- Thrombus aspiration data is insufficient to demonstrate a clear clinical prognostic impact, despite widespread adoption in Japan for procedural advantages.
- Further research is required to determine which patient or lesion subsets most benefit from thrombus removal or necessitate distal protection strategies.
Impact:
- Current evidence does not conclusively support routine use of thrombus removal devices for improving clinical outcomes in AMI.
- The findings highlight the need for targeted research to optimize thrombus removal strategies and patient selection.
- Understanding specific patient/lesion characteristics is crucial for advancing reperfusion therapy in acute myocardial infarction.
Abstract:
Reducing thrombus burden before percutaneous coronary intervention (PCI) may lead to better myocardial reperfusion in patients with acute myocardial infarction (AMI). Thus, several types of devices have been developed to remove intracoronary thrombus during reperfusion therapy, which includes X-sizer, AngioJet, and aspiration devices. There are two important randomized studies by using X-sizer and AngioJet to evaluate the efficacy of thrombus removal, which implied the possible benefit in myocardial tissue reperfusion, but could not prove the beneficial impact on clinical outcomes. As for thrombus aspiration, there also seems to be no data to demonstrate its clinical impact on prognosis. However, the aspiration therapy has been accepted widespread in Japan, mainly because of the practical benefit to clarify the lesion morphology with easy manipulation. Further studies are needed to demonstrate the characteristics of patient or lesion characteristics which are likely to benefit most by thrombus removal therapy or which demand to perform distal protection strategy.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
